Optimization of the antifungal metabolite production in Streptomyces libani isolated from northern forests soils in Iran

Document Type : Original Articles

Authors

1 Department of Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

2 Department of Mycology, Pasteur Institute of Iran, Tehran, Iran

10.18502/cmm.6.4.5333

Abstract

Background and Purpose: Soil bacteria have extreme population diversity among natural sources and are able to produce a wide array of antifungal metabolites. This study aimed to isolate and identify the bioactive metabolite-producing bacteria from forest soils and evaluate their antimicrobial potent against some pathogenic organisms.
Materials and Methods: In this study, soil samples were screened for antifungal activity against Aspergillus fumigatus on glucose-yeast extract (GY) agar using a visual agar plate assay method. All growing bacteria were examined for antifungal activity, and antagonistic bacteria were identified based on 16S ribosomal RNA sequence analysis. For optimization of the production of antifungal bioactive metabolites, inhibitory bacteria were cultured on different culture conditions, including media, pH, temperature, and incubation time.
Results: In total, 110 bacterial strains were isolated from the forest soils and four species with high antifungal activity were identified as Streptomyces libani, Streptomyces angustmyceticus, Bacillus subtilis, and Sphingopyxis spp. on the basis of 16s ribosomal RNA sequencing. Dichloromethane extract of the starch casein broth culture filtrate of the S. libani (incubated at 30° C for five days) showed strong antifungal activity against A. fumigatus, Aspergillus niger, and Aspergillus flavus.
Conclusion: Based on the results, forest soils contain organisms with antifungal activity and could be considered as a good source for novel antifungal metabolites as effective and safe therapeutics.


 

Keywords


1. Szalewski DA, Hinrichs VS, Zinniel DK, Barletta RG. The pathogenicity of Aspergillus fumigatus, drug resistance, and nanoparticle delivery. Can J Microbiol. 2018; 64(7):439-53.
2. Vazquez JA, Miceli MH, Alangaden G. Invasive fungal infections in transplant recipients. Ther Adv Infect Dis. 2013;1(3):85-105.
3. Paulussen C, Hallsworth JE, Alvarez-Perez S, Nierman WC, Hamill PG, Blain D, et al. Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species. Microb Biotechnol. 2017; 10(2):296-322.
4. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005; 18(1):44-69.
5. Chowdhary A, Sharma C, Meis JF. Azole-resistant aspergillosis: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017; 216(Suppl 3):S436-44.
6. Rivero-Menendez O, Alastruey-Izquierdo A, Mellado E, Cuenca-Estrella M. Triazole resistance in Aspergillus spp.: a worldwide problem? J Fungi. 2016; 2(3):21.
7. Vincente MF, Basilio A, Cabello A, Pelaez F. Microbial natural products as a source of antifungals. Clin Microbiol Infect. 2003; 9(1):15-32.
8. Wang G, Li X, Wang Z. APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res. 2016; 44(D1):D1087-93.
9. Ranjbariyan A, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M. Antifungal activity of a soil isolate of Pseudomonas chlororaphis against medically important dermatophytes and identification of a phenazine-like compound as its bioactive metabolite. J Mycol Med. 2014; 24(2):e57-64.
10. Jasim B, Benny R, Sabu R, Mathew J, Radhakrishnan EK. Metabolite and mechanistic basis of antifungal property exhibited by endophytic Bacillus amyloliquefaciens BmB 1. Appl Biochem Biotech. 2016; 179(5):830-45.
11. Siahmoshteh F, Hamidi-Esfahani Z, Spadaro D, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M. Unraveling the mode of antifungal action of Bacillus subtilis and Bacillus amyloliquefaciens as potential biocontrol agents against aflatoxigenic Aspergillus parasiticus. Food Control. 2018; 89:300-7.
12. Jafari S, Aghaei SS, Afifi-Sabet H, Shams-Ghahfarokhi M, Jahanshiri Z, Gholami-Shabani M, et al. Exploration, antifungal and antiaflatoxigenic activity of halophilic bacteria communities from saline soils of Howze-Soltan playa in Iran. Extremophiles. 2018; 22(1):87-98.
13. Ranjbariyan AR, Shams-Ghahfarokhi M, Kalantari S, Razzaghi-Abyaneh M. Molecular identification of antagonistic bacteria from Tehran soils and evaluation of their inhibitory activities toward pathogenic fungi. Iran J Microbiol. 2011; 3(3):140-6.
14. Al-Dhabi NA, Esmail GA, Duraipandiyan V, Arasu MV, Salem-Bekhit MM. Isolation, identification and screening of antimicrobial thermophilic Streptomyces sp. Al-Dhabi-1 isolated from Tharban hot spring, Saudi Arabia. Extremophiles. 2016; 20(1):79-90.
15. Sharma P, Kalita MC, Thakur D. Broad spectrum antimicrobial activity of forest-derived soil actinomycete, Nocardia sp. PB-52. Front Microbiol. 2016; 7:347.
16. Ambavane V, Tokdar P, Parab R, Sreekumar ES, Mahajan GB, Mishra PD, et al. Caerulomycin A-An antifungal compound isolated from marine actinomycetes. Adv Microbiol. 2014; 4(9):567-78.
17. Shams-Ghahfarokhi M, Kalantari S, Razzaghi-Abyaneh M. Terrestrial bacteria from agricultural soils: versatile weapons against aflatoxigenic fungi. In: Razzaghi-Abyaneh M, editor. Aflatoxins: recent advances and future prospects. London: IntechOpen; 2013. P. 23-40.
18. Elleuch L, Shaaban M, Smaoui S, Mellouli L, Karray-Rebai I, Fguira LF, et al. Bioactive secondary metabolites from a new terrestrial Streptomyces sp. TN262. Appl Biochem Biotechnol. 2010; 162(2):579-93.
19. Kumar RR, Jadeja VJ. Characterization and partial purification of an antibacterial agent from halophilic actinomycetes Kocuria
sp. strain rsk4. Bioimpacts. 2018; 8(4):253-61.
20. Ganesan P, Reegan AD, David RH, Gandhi MR, Paulraj MG, Al-Dhabi NA, et al. Antimicrobial activity of some actinomycetes from Western Ghats of Tamil Nadu, India. Alexandria J Med. 2017; 53(2):101-10.
21. Al-Dhabi NA, Esmail GA, Duraipandiyan V, Arasu MV. Chemical profiling of Streptomyces sp. Al-Dhabi-2 recovered from an extreme environment in Saudi Arabia as a novel drug source for medical and industrial applications. Saudi J Bio Sci. 2019; 26(4):758-66.
22. Ahsan T, Chen J, Zhao X, Irfan M, Wu Y. Extraction and identification of bioactive compounds (eicosane and dibutyl phthalate) produced by Streptomyces strain KX852460 for the biological control of RhizoctoniasolaniAG-3 strain KX852461 to control target spot disease in tobacco leaf. AMB Express. 2017; 7(1):54.
23. Illakkiam D, Shankar M, Ponraj P, Rajendhran J, Gunasekaran P. Genome sequencing of a mung bean plant growth promoting strain of P. aeruginosa with biocontrol ability. Int J Genomics. 2014; 2014:123058.
24. Denning DW, Bowyer P. Editorial commentary: voriconazole resistance in Aspergillus fumigatus: should we be concerned? Clin Infect Dis. 2013; 57(4):521-3.
25. Jeans AR, Howard SJ, Al-Nakeeb Z, Goodwin J, Gregson L, Warn PA, et al. Combination of voriconazole and anidulafungin for treatment of triazole-resistant Aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2012; 56(10):5180-5.
26. Khebizi N, Boudjella H, Bijani C, Bouras N, Klenk HP, Pont F, et al. Oligomycins A and E, major bioactive secondary metabolites produced by Streptomyces sp. strain HG29 isolated from a Saharan soil. J Mycol Med. 2018; 28(1):150-60.
27. Subramani R, Aalbersberg W. Marine actinomycetes: an ongoing source of novel bioactive metabolites. Microbiol Res. 2012; 167(10):571-80.
28. Kim BS, Moon SS, Hwang BK. Isolation, identification, and antifungal activity of a macrolide antibiotic, oligomycin A, produced by Streptomyces libani. Can J Bot. 1999; 77(6):850-8.
29. Lyu A, Liu H, Che H, Yang L, Zhang J, Wu M, et al. Reveromycins A and B from Streptomyces sp. 3-10: antifungal activity against plant pathogenic fungi in vitro and in a strawberry food model system. Front Microbiol. 2017; 8:550.
30. Aliero AA, Ntulume I, Odda J, Okech MA. Production of novel antifungal compounds from actinomycetes isolated from waste dump soil in Western Uganda. Afr J Microbiol Res. 2017; 11(30):1200-10.
31. Caulier S, Nannan C, Gillis A, Licciardi F, Bragard C, Mahillon J. Overview of the antimicrobial compounds produced by members of the Bacillus subtilis group. Front Microbiol. 2019; 10:302.
32. Reddy NG, Ramakrishna DP, Rajagopal SV. Optimization of culture conditions of Streptomyces rochei (MTCC 10109) for the production of antimicrobial metabolites. Egypt J Biol. 2011; 13:21-9.
33. Kumar S, Kannabiran K. Antifungal activity of Streptomyces VITSVK5 spp. against drug resistant Aspergillus clinical isolates from pulmonary tuberculosis patients. J Mycol Med. 2010; 20(2):101-7.
34. BSSN HB, Muvva V, Munaganti RK, Naragani K, Konda S, Dorigondla KR. Production of antimicrobial metabolites by Streptomyces lavendulocolor VHB-9 isolated from granite mines. Braz Arch Biol Technol. 2017; 60:1-13.
35. Aouiche A, Bijani C, Zitouni A, Mathieu F, Sabaou N. Antimicrobial activity of saquayamycins produced by Streptomyces spp. PAL114 isolated from a Saharan soil. J Mycol Med. 2014; 24(2):e17-23.
Volume 6, Issue 4
December 2020
Pages 20-26
  • Receive Date: 27 June 2020
  • Revise Date: 13 November 2020
  • Accept Date: 15 November 2020
  • First Publish Date: 22 November 2020
  • Publish Date: 01 December 2020